XO1 acquired by Janssen Pharmaceutical Companies of Johnson & Johnson

Please follow and like us:
Facebook
Google+
https://www.confluencetax.com/xo1-acquired-by-janssen-pharmaceutical-companies-of-johnson-johnson/
YouTube
LINKEDIN

XO1

 

 

 

 

Confluence Tax is delighted to have assisted XO1 with its sale to Janssen Pharmaceuticals.

Click here to view article

Commenting on our role, Richard Mason, CEO of XO1, said:

Confluence Tax LLP are clearly streets ahead of everybody, including the big 4 firms, when it comes to providing professional taxation advice in the biotech space”.